TickerFacts.

Compare

Orasure Technologies Inc vs Anika Therapeutics, Inc. vs Xtant Medical Holdings, Inc. vs Kestra Medical Technologies, Ltd.

Latest annual figures from SEC filings. Each company is shown for its own most recent fiscal year, so period ends can differ. Select a figure to see its full history.

Latest fiscal yearOrasure Technologies Inc
OSUR		Anika Therapeutics, Inc.
ANIK		Xtant Medical Holdings, Inc.
XTNT		Kestra Medical Technologies, Ltd.
KMTS
Year ended2025-12-312025-12-312025-12-312026-04-30
Revenue$115.02M$112.82M$133.93M$95.13M
Revenue growth (YoY)-38.1%-5.9%+14.2%+59.0%
Gross margin41.9%56.6%62.9%51.4%
Operating margin-62.6%-9.8%5.4%-141.6%
Net margin-59.8%-9.6%3.7%-138.4%
Net income-$68.73M-$10.88M$4.97M-$131.61M
EPS (Diluted)-$0.94-$0.76$0.03-$2.43
Operating cash flow-$49.02M$11.19M$12.55M-$81.70M
Free cash flow-$53.22M$4.36M$10.16M-$116.59M
Cash & equivalents$199.28M$57.48M$17.05M$99.71M
Total assets$403.17M$190.27M$94.14M$358.46M
Total liabilities$62.34Mn/a$43.19M$98.81M
Shareholders' equity$340.83M$143.47M$50.95M$259.66M
Return on year-end equity-20.2%-7.6%9.8%-50.7%
Shares outstanding70.39M13.89M140.04M58.38M

n/a means the company did not report that line under the concept TickerFacts maps, not that it is zero.

Revenue, most recent five fiscal years

Fiscal yearOrasure Technologies IncAnika Therapeutics, Inc.Xtant Medical Holdings, Inc.Kestra Medical Technologies, Ltd.
Latest$115.02M
Ended 2025-12-31		$112.82M
Ended 2025-12-31		$133.93M
Ended 2025-12-31		$95.13M
Ended 2026-04-30
1 year earlier$185.83M
Ended 2024-12-31		$119.91M
Ended 2024-12-31		$117.27M
Ended 2024-12-31		$59.81M
Ended 2025-04-30
2 years earlier$405.47M
Ended 2023-12-31		$120.79M
Ended 2023-12-31		$91.30M
Ended 2023-12-31		$27.81M
Ended 2024-04-30
3 years earlier$387.48M
Ended 2022-12-31		$113.83M
Ended 2022-12-31		$57.97M
Ended 2022-12-31		n/a
4 years earlier$233.67M
Ended 2021-12-31		$147.79M
Ended 2021-12-31		$55.26M
Ended 2021-12-31		n/a